No studies on endothelial dysfunction and CXCL6 seem available in the literature (Table S2), but our results showing significantly reduced levels of CXCL6 during the intervention suggest it may have a role as a biomarker of endothelial inflammation, as the endothelial function had improved at the post‐intervention phase. This evidence concerns the gene CXCL6 and endothelial dysfunction.